SPAC27F1.10 Antibody

What is SPAC27F1.10 and why is it significant for research?

SPAC27F1.10 is an uncharacterized membrane protein encoded by the SPAC27F1.10 gene locus in Schizosaccharomyces pombe (fission yeast). Despite lacking experimentally confirmed biological functions, studying this protein is important for understanding the complete proteome of S. pombe, which serves as a model organism for eukaryotic cell biology. The protein is particularly interesting due to its membrane localization, suggesting potential roles in cellular transport, signaling, or structural organization.

What is known about the structure and characteristics of SPAC27F1.10?

SPAC27F1.10 is classified as a small hydrophobic membrane protein. While detailed structural information remains limited, recombinant forms of the protein have been produced for biochemical and structural studies. The protein exhibits typical membrane protein characteristics, including hydrophobic domains that anchor it within cellular membranes. Its genomic context places it adjacent to SPAC27F1.06c (a peptidyl-prolyl isomerase), though no functional linkage has been established between these proteins.

How does SPAC27F1.10 compare to other uncharacterized membrane proteins in yeast?

SPAC27F1.10 shares challenges common to uncharacterized membrane proteins in yeast systems. When compared with other S. pombe uncharacterized proteins such as SPAC27E2.12, SPAC27F1.10 remains in an earlier stage of characterization. The table below compares several related proteins:

What approaches are used to generate antibodies against SPAC27F1.10?

Generating antibodies against SPAC27F1.10 typically involves using recombinant protein as an immunogen. The recombinant SPAC27F1.10 protein is synthesized in expression systems, commonly Saccharomyces cerevisiae, and often includes affinity tags to facilitate purification. The purified protein or specific peptide sequences derived from it are then used for immunization of host animals to generate polyclonal antibodies, or for more specialized monoclonal antibody development through hybridoma technology or phage display methods.

What validation methods ensure SPAC27F1.10 antibody specificity?

Validation of SPAC27F1.10 antibodies requires multiple approaches due to the uncharacterized nature of the target protein. Recommended validation protocols include:

• Western blot analysis comparing wild-type S. pombe with SPAC27F1.10 knockout strains

• Immunoprecipitation followed by mass spectrometry identification

• Immunofluorescence microscopy with peptide competition assays

• Orthogonal validation using epitope-tagged SPAC27F1.10 constructs

• Cross-reactivity testing against related membrane proteins

These validation steps are crucial for establishing antibody specificity, particularly for an uncharacterized protein where functional assays might not be immediately available.

How can SPAC27F1.10 antibodies be used to determine protein localization?

SPAC27F1.10 antibodies enable subcellular localization studies through immunofluorescence microscopy and subcellular fractionation techniques. For membrane proteins like SPAC27F1.10, optimization of fixation and permeabilization protocols is critical to preserve membrane structure while allowing antibody access. Researchers should consider:

• Testing multiple fixation methods (paraformaldehyde, methanol, or combined approaches)

• Employing specialized detergents for membrane protein permeabilization (e.g., saponin, digitonin)

• Using correlative approaches with organelle markers

• Confirming localization with GFP-tagged constructs as complementary evidence

This multi-method approach helps overcome challenges associated with membrane protein detection and provides reliable localization data.

What are effective strategies for using SPAC27F1.10 antibodies in protein-protein interaction studies?

SPAC27F1.10 antibodies are valuable tools for identifying protein interaction partners through:

• Co-immunoprecipitation (Co-IP) experiments, optimized for membrane protein solubilization

• Proximity labeling approaches, where SPAC27F1.10 antibodies validate interactions identified through BioID or APEX methods

• Pull-down assays using recombinant SPAC27F1.10 protein followed by antibody detection of interacting partners

• Crosslinking immunoprecipitation (CLIP) for capturing transient or weak interactions

When designing these experiments, researchers should consider using mild detergents (e.g., digitonin, CHAPS) for membrane protein extraction and maintaining native protein conformations during interaction studies.

How can researchers overcome the challenges of SPAC27F1.10 insolubility and aggregation?

Membrane proteins like SPAC27F1.10 present significant challenges for antibody-based detection due to their hydrophobic nature. Recommended approaches include:

Recent advances in cell-free systems with lipid sponge droplets, similar to those used for E. coli AcrZ, could potentially facilitate functional assays for SPAC27F1.10 antibody validation.

What are the best practices for storage and handling of SPAC27F1.10 antibodies?

Proper storage and handling of antibodies against membrane proteins like SPAC27F1.10 are critical for maintaining activity:

• Store antibody aliquots at -80°C for long-term storage

• For working solutions, maintain at -20°C with 50% glycerol

• Avoid repeated freeze-thaw cycles (limit to <5)

• Include protease inhibitors in working solutions

• Perform regular validation tests to confirm activity retention

• Consider stabilizing additives such as BSA (0.1-1%) for dilute solutions

These practices help preserve antibody function, particularly important when working with challenging membrane protein targets that may require extended incubation periods or specialized detection protocols.

How can SPAC27F1.10 antibodies aid in functional characterization studies?

For uncharacterized proteins like SPAC27F1.10, antibodies serve as critical tools for functional discovery through:

• Perturbation studies: Introducing antibodies into permeabilized cells to disrupt protein function

• Chromatin immunoprecipitation (if nuclear associations are suspected)

• Developmental or stress-response profiling: Monitoring protein expression under various conditions

• Post-translational modification detection: Using modification-specific antibodies once potential sites are identified

• Structural studies support: Antibody fragments (Fab) to stabilize protein for cryo-EM analysis

Additionally, researchers can use SPAC27F1.10 antibodies in comparative studies across different yeast species to investigate evolutionary conservation of function for this uncharacterized protein family.

What bioinformatic approaches complement SPAC27F1.10 antibody experimental data?

Integrating antibody-derived experimental data with bioinformatic analyses provides a more comprehensive understanding of SPAC27F1.10:

• Structural prediction: Using antibody epitope accessibility data to refine membrane topology models

• Homology detection: Identifying distant homologs in other species through iterative profile searches

• Co-expression network analysis: Correlating SPAC27F1.10 expression patterns with characterized genes

• Genome-wide interaction screens: Interpreting antibody-based localization in context of genetic interaction data

• Domain identification: Using antibody accessibility data to validate predicted functional domains

Researchers can leverage database identifiers such as KEGG: spo:SPAC27F1.10 and STRING: 4896.SPAC27F1.10.1 to access comprehensive bioinformatic resources for this protein.